BIO VIEW (Israel) Valuation

Do you wonder what the value of BIO VIEW is? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as BIO VIEW, is its stock price multiplied by the total number of shares outstanding, calculating BIO VIEW's enterprise value requires a different approach. It uses BIO VIEW's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
BIO VIEW prevailing Real Value cannot be determined due to lack of data. The current price of BIO VIEW is S0.0. Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Our model approximates the value of BIO VIEW from reviewing the firm fundamentals such as profit margin of (5.03) %, and Return On Equity of (6.08) % as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we favor taking in undervalued instruments and trading overvalued instruments since, in the future, asset prices and their ongoing real values will blend.
  
BIO VIEW Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as BIO VIEW's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

BIO VIEW Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining BIO VIEW's current stock value. Our valuation model uses many indicators to compare BIO VIEW value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BIO VIEW competition to find correlations between indicators driving BIO VIEW's intrinsic value. More Info.
BIO VIEW is number one stock in price to book category among related companies. It is number one stock in beta category among related companies . The ratio of Price to Book to Beta for BIO VIEW is about  375.04 . Comparative valuation analysis is a catch-all model that can be used if you cannot value BIO VIEW by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BIO VIEW's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BIO VIEW's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates BIO VIEW's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in BIO VIEW and how it compares across the competition.
Check out Trending Equities. You can also try Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Tools for BIO VIEW Stock

When running BIO VIEW price analysis, check to measure BIO VIEW's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO VIEW is operating at the current time. Most of BIO VIEW's value examination focuses on studying past and present price action to predict the probability of BIO VIEW's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BIO VIEW's price. Additionally, you may evaluate how the addition of BIO VIEW to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go